Blackcrane Capital, LLC
CIK
1720745
Location
BELLEVUE, WA
Portfolio Value
Micro
$11,061,868
Diversification
Moderately concentrated
Filing Date
Global Rank
#6,564
/ 6,856
▼ 680
· as of Mar 2022
Top Industry
Banks - Regional
32.0%
Period ended 4 years ago
Filed May 12, 2022 · 4y
9 quarters · since Mar 2020
Portfolio Concentration
6 tracked positions · as of Mar 31, 2022 · Δ vs Dec 31, 2021Top Position
32.0%
+5.1 pts
Top 5
96.7%
+4.0 pts
Top 10
100.0%
0.0 pts
HHI
2,283
Moderately concentrated+322
Portfolio Trend
9 quarters · across all stocks
Sector Breakdown
As of Mar 31, 2022| Sector | % Portfolio | Value |
|---|---|---|
| Technology | 39.9% | $4,419,072 |
| Financial Services | 32.0% | $3,545,303 |
| Healthcare | 28.0% | $3,097,493 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increasedNo qualifying positions this quarter.
Trimmed
Positions the filer reduced
6 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| PROF | Profound Medical Corp. | −746,351 | 255,292 | $2,297,628 | |
| RCEL | AVITA Medical, Inc. | −411,547 | 43,324 | $367,387 | |
| WIX | Wix.com Ltd. | −38,835 | 21,643 | $2,260,827 | |
| NICE | NICE Ltd. | −31,783 | 9,855 | $2,158,245 | |
| HDB | Hdfc Bank Ltd | −12,823 | 57,807 | $3,545,303 | |
| TAK | Takeda Pharmaceutical Co Ltd | −937 | 30,201 | $432,478 | |
| No positions match the current search. | |||||
New Positions
Positions the filer opened this quarterNo qualifying positions this quarter.
6 tracked positions ·
$11,061,868 total
· filing declares
436,799 positions · $16,325,000
· as of Mar 31, 2022
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| HDB |
Hdfc Bank Ltd
Financial Services
|
Reduced | 57,807 | $3,545,303 | 32.05% | |
| PROF |
Profound Medical Corp.
Healthcare
|
Reduced | 255,292 | $2,297,628 | 20.77% | |
| WIX |
Wix.com Ltd.
Technology
|
Reduced | 21,643 | $2,260,827 | 20.44% | |
| NICE |
NICE Ltd.
Technology
|
Reduced | 9,855 | $2,158,245 | 19.51% | |
| TAK |
Takeda Pharmaceutical Co Ltd
Healthcare
|
Reduced | 30,201 | $432,478 | 3.91% | |
| RCEL |
AVITA Medical, Inc.
Healthcare
|
Reduced | 43,324 | $367,387 | 3.32% |
Covers the securities this platform tracks: U.S.-listed common stock and the put/call positions reported on it. A 13F can also report security types outside that coverage — preferred shares, bonds, warrants, untracked share classes — so the filing's own declared total can exceed the figures above. The source filing is linked at the top of this table.